Navigation Links
Inovio Pharmaceuticals' Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
Date:3/14/2011

delivered with Inovio's electroporation device; the 12-patient comparison group will receive standard-of-care treatment alone. The study has received approval from the Swedish Medical Products Agency and local ethical committee.

"If we can repeat the Phase I results in this phase IIb study there is certainly a possibility that vaccination with ChronVac-C® before drug therapy could become a part of the standard of care therapy for patients with chronic hepatitis C-virus infection. In particular, we hope that vaccination with this novel therapy will result in a considerable shortening of the duration of interferon and ribavirin treatment," said Anders Vahlne, CEO of ChronTech Pharma AB.

Dr. J. Joseph Kim, Inovio's president and CEO, said: "We are encouraged by the phase I results showing the improved cure rate in patients who received the HCV vaccine followed by a SOC drug therapy. Any improvement to the HCV standard of care response rates would be well-received by HCV patients and practitioners. We are pleased to collaborate in this advancement of ChronVac-C®, using Inovio's innovative delivery technology, into Phase II."

About Hepatitis C Virus

Hepatitis C virus (HCV) infection is the most common chronic blood borne infection in the United States, where approximately 3.5 million persons have been chronically infected. Worldwide, about 300 million people have been infected with HCV. Based on current statistics for hepatitis C, it is estimated that 8,000 to 10,000 people die each year from chronic liver disease caused by this condition. Chronic HCV infection is the leading indication for liver transplants in the United States. Total health costs associated with hepatitis C virus in the U.S. are estimated at more than $15 billion per year. No vaccine for HCV is currently available.

About Inovio's Electroporation-Based Delivery Technology

Inovio's electroporation-based DNA delivery systems can increase
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
2. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
3. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
6. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
7. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
8. Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
9. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
10. Conatus Pharmaceuticals Will Display HCV Clinical Trial Data at the International Liver Congress™ (EASL) in March
11. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... HILL, N.C. , Jan. 23, 2015 For the ... are in dealing with payers. Likewise, the importance of the ... - will only continue to grow as payer formularies and ... access therapies. At the same time, managed markets ...
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2No One-Size-Fits-All Remedy for Hernia Correction 2New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2
... 23 Select Medical Holdings Corporation ("Select") (NYSE: ... announced that it had received notice of the exercise ... 3,602,700 shares of Select,s common stock at a price ... on October 28, 2009, subject to customary closing conditions. ...
... NVAX ) a clinical-stage vaccine company, announced today that Fred ... Annual BIO Investor Forum 2009 at 11:00 am ... San Francisco, California. Mr. Driscoll will provide an overview of ... link to the live presentation can be accessed via the Company ...
Cached Medicine Technology:Select Medical Holdings Corporation Announces Exercise of Underwriters' Option to Purchase Additional Shares 2Novavax to Present at 8th Annual BIO Investor Forum 2009 2
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
(Date:1/22/2015)... Weddingshe.com has added many trendy Champagne wedding dresses ... in the past three years. Today, the business announces a ... to the sales manager of the company, this is on ... This point can be reflected on the discounted wedding dresses ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 As ... of overall health care gains momentum worldwide, Rev. Eric ... HealthCare Chaplaincy Network (HCCN), will be the keynote ... spiritual care in Israel’s public health system. , The conference, ...
(Date:1/22/2015)... January 22, 2015 State Forestry Institute ... management system with support from GEOSYSTEMS, a dedicated Hexagon ... solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... as well as point clouds and documents. This effort ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... adults on Medicare reports drinking more alcohol than is ... , Even though alcohol problems are more prevalent ... are consuming alcohol in amounts that exceed recommended guidelines, ... Universitys Heller School for Social Policy and Management. The ...
... Year Revenue Up 47.3% and Net Income Up 63.5% ... Company Declares Cash Dividend of US$0.18 ... Mindray,Medical International Limited (NYSE: MR ), a leading ... a rapidly growing,international presence, today announced its selected unaudited ...
... infertility risks, experts say , , WEDNESDAY, March 5 ... targeted treatment than standard chemotherapy, the effective and much-touted ... women still in their reproductive years, imatinib (Gleevec) might ... future, according to a case report published as a ...
... WALNUT CREEK, Calif., March 5 Longs Drug,Stores ... income from,continuing operations for the fourth quarter ended ... or $1.00 per diluted share, including a,$1.1 million ... of seven,California stores. Income from continuing operations for ...
... MED ) announced today that it will release fourth quarter ... 2007 on,Wednesday, March 12, 2008 after the market closes. The ... results on Thursday, March 13,2008 at 11:00 a.m. ET., ... or,(201) 689-8567, or can listen via a live Internet web ...
... 2008 The American Cancer Society, the American College ... on Colorectal Cancer (a group that comprises representatives ... Association, and American Society for Gastrointestinal Endoscopy) have ... cancer screening. The guidelines add two new tests ...
Cached Medicine News:Health News:New study sheds light on excessive drinking among the elderly 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 2Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 3Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 4Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 5Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 6Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 7Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 8Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 9Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 10Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 11Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 12Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 13Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 14Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 15Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 16Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 17Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 18Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 19Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 20Health News:Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results 21Health News:Gleevec May Disrupt Ovarian Function 2Health News:Gleevec May Disrupt Ovarian Function 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 2Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 3Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 4Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 5Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 6Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 7Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 8Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 9Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 10Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 11Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 12Health News:Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008 13
Provides wrist stability with moderate motion restriction, making it ideal for the workplace...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... UNO Splint fits small, medium, and large - ... includes both dorsal and volar stays with D-ring ... those experiencing symptoms of Carpal Tunnel Syndrome, sprains ... - stock one splint to comfortably fit a ...
... brace is designed for the management ... The anatomically correct design achieves total ... optimal control of ulnar segments. Full ... is permitted to prevent problems associated ...
Medicine Products: